Inventiva, Developer of Potential Therapy for Systemic Sclerosis, Awarded at 4th World Congress for Its Innovative Approach
Idiopathic Pulmonary Fibrosis, News, Scleroderma
Inventiva, a drug discovery company focused on the treatments of fibrotic, oncological, and rare diseases, announced that the organizing committee of the 4th Systemic Sclerosis World Congress in Lisbon, Portugal, which ... Read more